Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post Hoc Responder Analysis from a Randomized Trial in Patients with Moderate to Severe Alzheimer's Disease (P04.197)
Year: 2012
Type: conference-abstract
Source: Neurology
Authors: J. Cummings, S. Hendrix, M. Miller, V. Pejovic, S. Graham, M. Tocco
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1978005665
